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o r i g i n a l a r t i c l e
Electronic Surveillance for Healthcare-Associated
Central Line–Associated Bloodstream Infections
Outside the Intensive Care Unit
Keith F. Woeltje, MD, PhD;1,2 Kathleen M. McMullen, MPH, CIC;3 Anne M. Butler, MS;4
Ashleigh J. Goris, RN, MPH, CIC;5 Joshua A. Doherty, BS2
background. Manual surveillance for central line–associated bloodstream infections (CLABSIs) by infection prevention practitioners
is time-consuming and often limited to intensive care units (ICUs). An automated surveillance system using existing databases with patient-
level variables and microbiology data was investigated.
methods. Patients with a positive blood culture in 4 non-ICU wards at Barnes-Jewish Hospital between July 1, 2005, and December
31, 2006, were evaluated. CLABSI determination for these patients was made via 2 sources; a manual chart review and an automated review
from electronically available data. Agreement between these 2 sources was used to develop the best-fit electronic algorithm that used a set
of rules to identify a CLABSI. Sensitivity, specificity, predictive values, and Pearson’s correlation were calculated for the various rule sets,
using manual chart review as the reference standard.
results. During the study period, 391 positive blood cultures from 331 patients were evaluated. Eighty-five (22%) of these were confirmed
to be CLABSI by manual chart review. The best-fit model included presence of a catheter, blood culture positive for known pathogen or
blood culture with a common skin contaminant confirmed by a second positive culture and the presence of fever, and no positive cultures
with the same organism from another sterile site. The best-performing rule set had an overall sensitivity of 95.2%, specificity of 97.5%,
positive predictive value of 90%, and negative predictive value of 99.2% compared with intensive manual surveillance.
conclusions. Although CLABSIs were slightly overpredicted by electronic surveillance compared with manual chart review, the method
offers the possibility of performing acceptably good surveillance in areas where resources do not allow for traditional manual surveillance.
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Surveillance for healthcare-associated infections has long
been recognized as a vital component of effective infection
prevention programs.1 Standardized surveillance has clearly
aided the steady reduction of central line–associated blood-
stream infection (CLABSI) rates in intensive care unit (ICU)
patients by allowing the impact of infection prevention efforts
to be measured.2 However, using the definitions of the Centers
for Disease Control and Prevention’s National Healthcare
Surveillance Network (NHSN) is very labor intensive and
time-consuming. For this reason, CLABSI surveillance efforts
are often limited to ICUs, which represent a fairly well-
defined patient population with historically relatively high
central line use. In addition, there has been an implicit as-
sumption that ICU patients are at higher risk for CLABSI.
However, a number of studies have indicated that non-ICU
patients have an equally high risk of CLABSI.3,4 Furthermore,
in many hospitals there may actually be more patients with
catheters outside the ICU than in it.5 The lower utilization
rates of central lines outside the ICU and the larger, more
widely distributed population exacerbate the effort required
for adequate surveillance of CLABSI by means of the tradi-
tional manual methods. The increasing availability of patient
and laboratory data offer the potential for automating the
process. A preliminary study suggested that this approach was
feasible, but the study was hampered by the lack of an elec-
tronic source of central line data.6 We report here a pilot
project to evaluate totally electronic surveillance of CLABSI.
methods
Study Population
Barnes-Jewish Hospital is a 1,250-bed tertiary care teaching
hospital affiliated with Washington University School of Med-
icine in St. Louis, Missouri. Two general medical wards and
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table 1. Performance of Individual Rules and Aggregate Rule Sets
No. of BSIs
confirmed
by rule set Sensitivity, % Specificity, % PPV, % NPV, % k
Pearson’s
correlation
Rule 1: hospital acquired 239 100 (95.7–100) 57.9 (52.8–62.9) 35.6 (29.8–41.8) 100 (98.2–100) .342 .454
Rule 2a: non-CSC 238 100 (95.7–100) 58.2 (53.1–63.1) 35.7 (29.9–42.0) 100 (98.2–100) .344 .456
Rule 2b: non-CSC (with fever) 210 100 (95.7–100) 65.8 (60.9–70.5) 40.5 (34.1–47.2) 100 (98.4–100) .421 .516
Rule 3: CVC 229 95.3 (88.5–98.2) 59.5 (54.5–64.5) 35.4 (29.5–41.8) 98.2 (95.5–99.3) .389 .492
Rule 4a: no secondary BSI 396 91.7 (84.0–96.0) 13.1 (10.0–17.0) 19.7 (16.1–23.9) 87.3 (76.0–93.7) .020 .058
Rule 4b: no secondary BSI
(before only) 433 98.8 (93.6–99.8) 4.6 (2.9–7.3) 19.4 (16.0–23.4) 94.4 (74.2–99.0) .013 .069
Rule set 1, 2b, 3, 4a 80 87.1 (78.3–92.6) 98.4 (96.5–99.3) 92.5 (84.6–96.5) 97.0 (94.8–98.3) .874 .875
Rule set 1, 2b, 3, 4b 90 95.2 (88.5–98.2) 97.5 (95.4–98.7) 90.0 (82.1–94.7) 99.2 (97.2–99.6) .908 .908
Rule set 1, 2, 3, 4 92 87.1 (78.3–92.6) 95.1 (92.4–96.9) 80.4 (71.2–87.3) 96.9 (94.6–98.3) .796 .797
Rule set 1, 2a, 3, 4b 101 94.1 (87.0–97.5) 94.3 (91.4–96.2) 79.2 (70.3–86.0) 98.6 (96.7–99.4) .824 .829
Rule set 1, 2a, 3, 4c 85 91.8 (84.0–95.6) 98.1 (96.1–99.1) 91.8 (84.0–96.0) 98.1 (96.1–99.1) .899 .899
Rule set 1, 2a, 3, 4d 86 91.8 (84.0–96.0) 97.8 (95.8–98.9) 90.7 (82.7–95.2) 98.1 (96.1–99.1) .892 .892
note. Data in parentheses are 95% confidence intervals. Boldface type indicates the best-fit rule set. BSI, bloodstream infection; CSC,
common skin contaminant; CVC, central venous catheter; NPV, negative predictive value; PPV, positive predictive value.
2 general surgical wards were chosen for surveillance. These
units were selected to provide a variety of patient types, and
the anticipated patient volumes were within our ability to
conduct manual surveillance (routine surveillance by hospital
infection prevention was not in place in these units). All
patients on the surveillance wards with a positive blood cul-
ture between July 1, 2005, and December 31, 2006, were
included in the study. Human studies committee approval
for the project was obtained before initiation.
Manual Surveillance
Patients who had a positive blood culture were identified from
the hospital informatics database.7,8 The charts of these patients
were reviewed using a standardized data collection tool, and
data were entered into an SPSS data set. The data were reviewed
with a hospital epidemiologist to confirm a CLABSI using the
NHSN definitions current at the time. After the initial data
abstraction, NHSN criteria for CLABSI changed—specifically,
patients with a single culture positive for a common skin con-
taminant who received antimicrobial therapy no longer met
the definition for a CLABSI.9,10 Our manually collected data
set had sufficient information to allow reclassification of pa-
tients who no longer met the revised NHSN definition.
Electronic Surveillance
Patients on the surveillance wards with positive blood cultures
were identified from the hospital informatics database. Non-
organism concepts (eg, Aspergillus galactomannan) that were
reported to the database as “positive cultures” were filtered
from the data set before analysis. Additional electronically
available data (eg, positive cultures from other sites, labo-
ratory values, patient temperature, and presence of a central
line) were pulled by standardized query into an analysis data
set. A series of yes/no electronic rules applicable to the de-
termination of CLABSI were applied (similar to rules reported
by Trick et al6). These rules were then applied in different
combinations to determine which set of rules most closely
matched the CLABSI determination from the manual sur-
veillance. The individual rules are as follows:
1. Hospital acquired: positive blood culture was obtained 48
hours or more after hospital admission.
2. Non–common skin contaminant:
a. Culture positive for non–common skin contaminant
pathogen or culture positive for common skin contam-
inant9 that was confirmed with another positive culture
of the same organism within 3 days.
b. Culture positive for non–common skin contaminant
pathogen or culture positive for common skin contam-
inant9 that was confirmed with another positive culture
of the same organism within 3 days and the patient had
a fever (temperature more than 38.0C within 48 hours
of the blood culture).
3. Central venous catheter: patient had a central venous cath-
eter in place at the time of culture or discontinued within
48 hours before culture.
4. No secondary bloodstream infection: no positive culture
of the same organism from any other body site (many
combinations were evaluated, and a selected few are shown
below).
a. Anytime during the admission.
b. Anytime during the admission before the blood culture
date.
c. Anytime during the admission before or within 7 days
after the blood culture date.
d. Anytime during the admission within 14 days before or
7 days after the blood culture date.
Any other positive blood culture within 7 days of the
CLABSI culture was assumed to be part of the same infection
and so was not counted as a new infection. Any positive
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figure 1. Comparison of unit-level central line–associated bloodstream infection rates (cases per 1,000 central line–days) over time.
culture with the same organism as the CLABSI culture within
14 days of the initial culture was also assumed to be part of
the same CLABSI.
Sensitivity, specificity, predictive values, and Pearson’s cor-
relation were calculated for the various new rule sets, using
manual chart review as the reference standard. For the best-
fit model, x2 analysis was completed comparing the manual
and electronic CLABSI rates.
results
During the study period, 391 positive blood cultures from
331 patients were evaluated. Eighty-five (22%) of these were
confirmed to be CLABSI by manual chart review. Individual
rules, not unexpectedly, performed relatively poorly. The best-
fit model, which included rules 1, 2b, 3, and 4b, predicted
90 CLABSIs (23%; Table 1). The CLABSI rate by manual
surveillance was 6.37 cases per 1,000 central line–days (95%
confidence interval, 5.0–7.7) versus 6.75 cases per 1,000 cen-
tral line–days (95% confidence interval, 5.4–8.1; ).Pp .76
CLABSIs remain slightly overpredicted compared with
manual chart review. Preliminary analyses of the original data
set (before the change in NHSN criteria; data not shown)
evaluated specific sites (eg, wounds and urine) alone and in
a variety of combinations, but they did not result in im-
provement over using all culture sites to eliminate potential
secondary bloodstream infections; these analyses were not
repeated with the updated data set. Likewise, analyses of the
initial data set evaluating the utility of incorporating the pa-
tient’s white blood cell count did not yield improved per-
formance and so were not repeated in this set of analyses.
In addition to overall performance, the performance of the
best-fit model on a month-to-month basis for each ward was
determined (Figure 1). While electronic surveillance tended
to predict higher CLABSI rates than manual surveillance,
overall the trend lines were comparable. In ward 1, the num-
ber of cases from manual surveillance was 26, whereas elec-
tronic surveillance found 33; in ward 2, 13 and 12 cases were
found, respectively; in ward 3, 26 and 27 cases were found,
respectively; and in ward 4, 20 and 18 cases were found,
respectively ( for the comparison of manual to elec-P 1 .5
tronic CLABSI rates for each individual ward).
discussion
A variety of studies have proposed electronic methods of
surveillance for bloodstream infections in general.11-14 How-
ever, most institutions have focused on CLABSIs, because
these seem more amenable to prevention interventions. The
study by Trick et al6 provided a solid step toward performing
automated surveillance for CLABSI, but those investigators
did not have access to central line data electronically. Our
non-icu clasbi electronic rates 1089
current study shows results comparable to, if not slightly
better than, those of Trick and colleagues and has the ad-
vantage that surveillance could be done completely electron-
ically. One potential weakness of our current study is that
after developing the rules we did not validate them on a
separate set of patients. As noted below, we are in the process
of implementing these rules in multiple hospitals, which will
allow for additional validation.
Our electronic surveillance has overall higher rates than
manual surveillance. At least some of the infections that were
identified electronically were likely secondary infections that
did not have a site culture that met our electronic criteria
(data not shown). Conversely, we may be eliminating true
CLABSIs if the same organism from another site does not
represent a true secondary infection (eg, Candida in a sputum
sample). While this may argue for including some element
of human review, there may be advantages to a completely
objective surveillance method. A steady body of literature has
indicated the existence of significant interrater variation in
determining the presence of healthcare-associated infec-
tions.15-17 There is no evidence to suggest that interrater re-
liability improves with years of experience, and even within
institutions there appears to be significant interobserver var-
iations in determining whether a patient has a CLABSI.18 This
variability, combined with less comprehensive case finding,
tends to lead toward underreporting of CLABSI by traditional
surveillance.6,19-21 Thus, while electronic surveillance may re-
port a higher rate than traditional surveillance, the “true rate”
is probably somewhere in between. Since we did not have
traditional manual surveillance in place in the study units,
we were not able to validate this assumption as part of our
study. However, a pilot validation study comparing our al-
gorithm with traditional surveillance rates in our ICUs did
find that the “validated rates” were between the electronic
rates and the rates reported by infection control (data not
shown).
Fully automated electronic surveillance for CLABSI outside
the ICU offers the potential for performing whole-house
CLABSI surveillance without requiring a dramatic increase
in resources. This extended scope may help hospitals comply
with regulatory requirements for performing surveillance for
CLABSI, such as the Joint Commission’s National Patient
Safety Goals. Because this method uses different definitions
than traditional surveillance, healthcare personnel should not
try to compare the electronic rates with NHSN rates. In par-
ticular, electronic surveillance rates will include unconfirmed
secondary bloodstream infections, and “zero” rates cannot
be expected. Nevertheless, we believe that electronic surveil-
lance can provide valuable insight into areas of the hospital
with better or worse CLABSI performance to help us target
our improvement interventions. The electronic surveillance
will also show the impact of such interventions. To assist in
the acceptance of fully automated surveillance in non-ICU
areas, we have decided to use a term other than “CLABSI
rates” so as not to confuse them with NHSN-type rates. We
are using the term “NICER,” for non-ICU CLABSI electronic
rates. Currently, we are in the process of implementing
NICER surveillance at all BJC HealthCare facilities.
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